Review
doi: 10.1007/BF00145677.
Antibiotic treatment of rickettsiosis, recent advances and current concepts
Affiliations
- PMID: 1884779
- DOI: 10.1007/BF00145677
Item in Clipboard
Review
Antibiotic treatment of rickettsiosis, recent advances and current concepts
Eur J Epidemiol.
1991 May.
Abstract
The author reviews the recent advances in the treatment of Mediterranean Spotted Fever and Q fever. In mediterranean spotted fever (M.S.F.), in vitro and preliminary in vivo data support the place of quinolones and josamycin in the treatment of M.S.F. In children josamycin could become the first choice drug as well as in pregnant woman. In Q fever chronic disease should be treated using a combination of antibiotic (doxycycline + quinolones) for a minimum of 3 years.
Similar articles
-
Comparison of different antibiotic regimens for therapy of 32 cases of Q fever endocarditis.Antimicrob Agents Chemother. 1991 Mar;35(3):533-7. doi: 10.1128/AAC.35.3.533. Antimicrob Agents Chemother. 1991. PMID: 2039204 Free PMC article. Clinical Trial.
-
Antibiotic susceptibility of rickettsia and treatment of rickettsioses.Eur J Epidemiol. 1989 Dec;5(4):432-5. doi: 10.1007/BF00140135. Eur J Epidemiol. 1989. PMID: 2606171
-
Randomized Trial of Clarithromycin for Mediterranean Spotted Fever.Antimicrob Agents Chemother. 2015 Dec 28;60(3):1642-5. doi: 10.1128/AAC.01814-15. Antimicrob Agents Chemother. 2015. PMID: 26711765 Free PMC article. Clinical Trial.
-
Antimicrobial therapies for Q fever.Expert Rev Anti Infect Ther. 2013 Nov;11(11):1207-14. doi: 10.1586/14787210.2013.840534. Epub 2013 Sep 27. Expert Rev Anti Infect Ther. 2013. PMID: 24073941 Free PMC article. Review.
-
[Present stage of chemotherapy and chemoprophylaxis of rickettsiosis and Q fever].Antibiot Khimioter. 2011;56(11-12):34-44. Antibiot Khimioter. 2011. PMID: 22856156 Review. Russian.
Cited by
-
Targeted knockout of the Rickettsia rickettsii OmpA surface antigen does not diminish virulence in a mammalian model system.mBio. 2015 Mar 31;6(2):e00323-15. doi: 10.1128/mBio.00323-15. mBio. 2015. PMID: 25827414 Free PMC article.
-
Bacteriostatic and bactericidal activities of tigecycline against Coxiella burnetii and comparison with those of six other antibiotics.Antimicrob Agents Chemother. 2009 Jun;53(6):2690-2. doi: 10.1128/AAC.01424-08. Epub 2009 Mar 30. Antimicrob Agents Chemother. 2009. PMID: 19332671 Free PMC article.
-
In vitro susceptibility of Coxiella burnetii to linezolid in comparison with its susceptibilities to quinolones, doxycycline, and clarithromycin.Antimicrob Agents Chemother. 2001 Nov;45(11):3276-8. doi: 10.1128/AAC.45.11.3276-3278.2001. Antimicrob Agents Chemother. 2001. PMID: 11600400 Free PMC article.
-
In vitro susceptibility of Coxiella burnetii to trovafloxacin in comparison with susceptibilities to pefloxacin, ciprofloxacin, ofloxacin, doxycycline, and clarithromycin.Antimicrob Agents Chemother. 1998 Oct;42(10):2747-8. doi: 10.1128/AAC.42.10.2747. Antimicrob Agents Chemother. 1998. PMID: 9756789 Free PMC article.
-
In vitro activities of ceftriaxone and fusidic acid against 13 isolates of Coxiella burnetii, determined using the shell vial assay.Antimicrob Agents Chemother. 1993 Mar;37(3):491-4. doi: 10.1128/AAC.37.3.491. Antimicrob Agents Chemother. 1993. PMID: 8460917 Free PMC article.